Abstract
This study assessed the duration of action of single doses of ranitidine (75 mg), cimetidine (200 mg), or placebo on intragastric acidity in healthy subjects. When dosed with placebo, mean daytime intragastric acidity (0–10 hr after dose) was 37.62 mmol/liter, decreasing to 17.21 mmol/liter (mean decrease 59%; P < 0.001 vs placebo) and 25.06 mmol/liter (mean decrease 35%; P < 0.001 vs placebo) when treated with ranitidine and cimetidine, respectively. Ranitidine inhibited intragastric acidity to a greater degree than cimetidine (P < 0.001). Mean nighttime (10–20 hr after-dose) intragastric acidity when dosed with placebo was 34.37 mmol/liter, decreasing to 29.06 mmol/liter (mean decrease 18%; P = 0.027 vs placebo) when dosed with ranitidine and remaining virtually unchanged at 33.85 mmol/liter (mean decrease 2%; NS vs. placebo) when dosed with cimetidine. Ranitidine inhibited acidity to a greater degree than cimetidine (P = 0.043). The inhibitory effect of ranitidine, 75 mg, on intragastric acidity can be detected from 0–15 hr after an oral dose. Cimetidine 200 mg has little inhibitory effect beyond 10 hr.
Similar content being viewed by others
REFERENCES
Committee on the Safety of Medicines. Medicines newly released for self-medication:Curr Probl Pharmacovigil 20:4, 1994
Mason P: Has reclassification of GI drugs changes the treatment of disease? Pharm J 257:731–732, 1996
Reilly TG, Mann SG, Panos MZ, Walt RP: Low-dose famotidine and cimetidine in single post-prandial doses: A placebo controlled comparative study of overnight pH. Gut 37:325–328, 1995
Reilly TG, Singh S, Cotterel J, Mann SG, Stauffer L, Walt RP: Low-dose famotidine and ranitidine as single post-prandial doses: a 3-period placebo-controlled comparative trial. Aliment Pharmacol Ther 10:749–755, 1996
Grimley, CE, Cotterel J, Mann SG, Stauffer L, Nwokolo CU: Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo. Aliment Pharmacol Ther 11:881–885, 1997
Grimley CE, Constantinides S, Snell CC Mills JG, Nwokolo CU: Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: A comparative study with cimetidine and placebo. Aliment Pharmacol The 11:875–879, 1997
Merki H, Witzel L, Walt RP, Cohnen E, Harre K, Heim J, Mappes A, Rohmel J: Day to day variation of 24 hour intragastric acidity. Gastroenterology 94:887–891, 1988
Dammann HG, Dreyer M, Kangah R, Wolf N: Gastric aspiration technique for pH recording: A critical evaluation of this method. Dig Dis Sci 8(suppl 1):3–9, 1990
Pounder RE, Lanzon-Miller S, Smith JTL, et al: Royal Free Hospital protocol for 24-hour intragastric acidity and plasma gastrin concentration. Dig Dis Sci 8(suppl 1):10–17, 1990
Pounder RE, Prewett EJ: Gastric secretion in health and disease. In The Stomach, Vol 3B. S Gustavsson, D Kumar, DY Graham (eds). London, Churchill Livingston. 1992, pp 53–79
Hunt RH, Cederberg C, Dent J, Halter F, Howden C, Marks I, Rune S, Walt R: Optimizing acid suppression for treatment of acid related diseases. Dig Dis Sci 40:24S–49S, 1995
Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH: Acid suppression in duodenal ulcer: A metanalysis to define optimal dosing with anti-secretory drugs. Gut 28:1120–1127, 1987
Bates S, Sjoden PS, Fellenius J, Nyren O: Blocked and nonblocked acid secretion and reported pain in ulcer, non-ulcer dyspepsia and normal subjects. Gastroenterology 97:376–383, 1989
Mann SG, Murakami A, McCarroll K, Rao AN, Cottrell J, Mehentee J, Morton R: Low-dose famotidine in the prevention of sleep disturbance caused by heartburn after an evening meal. Aliment Pharmacol Ther 9:395–401, 1995
Mann SG, Cottrell J, Murakami A, Stauffer L, Rao AN: Prevention of heartburn relapse by low-dose famotidine: A test meal model for duration of symptom control. Aliment Pharmacol Ther 11:121–127, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hamilton, M.I., Sercombe, J. & Pounder, R.E. Decrease of Intragastric Acidity in Healthy Subjects Dosed with Ranitidine 75 mg, Cimetidine 200 mg, or Placebo. Dig Dis Sci 47, 54–57 (2002). https://doi.org/10.1023/A:1013255201858
Issue Date:
DOI: https://doi.org/10.1023/A:1013255201858